(Q44562444)

4 December 2017

0 references

Current evidences on IL1B polymorphisms and lung cancer susceptibility: a meta-analysis (English)

1 reference

4 December 2017

Chenguang Li

1

1 reference

4 December 2017

Changli Wang

series ordinal

2

1 reference

4 December 2017

publication date

20 June 2013

1 reference

4 December 2017

1 reference

4 December 2017

volume

34

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

3477-3482

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-0925-6

4 December 2017

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Association between XPF polymorphisms and cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Evolution of interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

IL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Lack of Association between Polymorphisms in Inflammatory Genes and Lung Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Interleukin-1β gene polymorphisms associated with risk of lung cancer in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0925-6

Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers

21 January 2018

1 reference

12 December 2020

Polymorphisms in DNA repair genes and associations with cancer risk

1 reference

12 December 2020

Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers

1 reference

12 December 2020

The IL-1 family and inflammatory diseases.

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Previous lung disease and risk of lung cancer among men and women nonsmokers

1 reference

12 December 2020

Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.

1 reference

12 December 2020

Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study

1 reference

12 December 2020

10.1007/S13277-013-0925-6

Identifiers

DOI

1 reference

4 December 2017

1 reference